Design Therapeutics Inc (DSGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -8,280 | N/A | N/A |
| Depreciation Amortization | -66 | N/A | N/A |
| Other Working Capital | -811 | N/A | N/A |
| Other Operating Activity | 488 | 0 | 0 |
| Operating Cash Flow | $-8,669 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| Change In Deposits | -33,485 | N/A | N/A |
| PPE Investments | -76 | N/A | N/A |
| Investing Cash Flow | $-33,561 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Change In Short Term Borrowing | 200 | N/A | N/A |
| Common Stock Issued | 1 | N/A | N/A |
| Other Financing Activity | 44,331 | 0 | 0 |
| Financing Cash Flow | $44,532 | $N/A | $N/A |
| Beginning Cash Position | 77 | N/A | N/A |
| End Cash Position | 2,379 | N/A | N/A |
| Net Cash Flow | $2,302 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -8,669 | N/A | N/A |
| Capital Expenditure | -76 | N/A | N/A |
| Free Cash Flow | -8,745 | 0 | 0 |